drugset / Trial / NCT01823393

Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure

NCT01823393

Phase 4 Terminated 94 enrolled University Hospital, Montpellier
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess if the non use of heparin sodium during balloon aortic valvuloplasty reduces serious complications due to the procedure, by decreasing the rate of vascular and hemorrhagic complications without increasing the rate of ischeamic events.

Timeline

Start
2013-01-24
Primary completion
2016-10-22
Completion
2016-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 50 iu/kg Intravenous

Indications